Frequently Asked Questions

What does it mean if information is embargoed?

The embargo means information concerning the study cannot be published, broadcast, posted online, shared with non-journalists, or otherwise placed in the public domain until the time of the embargo.

What is the JAMA and JAMA Journals publication and embargo schedule?

JAMA:

JAMA is published on the first four Wednesdays of each month. All original contributions, editorials, letters and other content appearing in a particular issue of JAMA are embargoed for release the day before the publication’s issue date, on a Tuesday, at 3 PM Central Time (CT) [4 PM ET]. For example, an article appearing in the Wednesday, September 7, issue would be under embargo until Tuesday, September 6, at 3 PM CT. Select articles are also published online first, ahead of print.

The JAMA Journals

Online First: Select articles from the JAMA Internal Medicine and JAMA Neurology are published online ahead of print on the first four Mondays of a month.

Regular Issues: All JAMA Journals are published once a month, except for the JAMA Internal Medicine, which is published twice a month, and the JAMA Facial Plastic Surgery, which is published every other month. All information published in the JAMA Journals is embargoed until 3 PM Central Time on Mondays. The embargo schedule for the JAMA Journals is as follows:

First Monday:    JAMA Psychiatry
JAMA Pediatrics
Second Monday: JAMA Neurology
JAMA Ophthalmology
JAMA Internal Medicine #1 (two issues each month)
 Third Monday: JAMA Surgery
JAMA Otolaryngology—Head & Neck Surgery
JAMA Dermatology
JAMA Facial Plastic Surgery (every other month)
Fourth Monday: JAMA Internal Medicine #2

 

Are there ever exceptions to the JAMA embargo?

The JAMA embargo is strict and only the JAMA Media Relations Department is authorized to make changes to a study’s embargo time. Contact the department if you have a question concerning an embargo.

When do JAMA studies appear online?

JAMA studies are available online to PIOs and journalists the Thursday before the embargo at 3 p.m. (CT) (4 p.m. Eastern Time) at the JAMA For The Media website. Embargoed news releases are also available at this time on the For The Media site, EurekAlert! and Newswise. Abstracts of all JAMA studies are available to the public at the embargo time at jamanetwork.com.


For public affairs officers:

I’m a new PIO. How do I hear about new JAMA studies?

If the JAMA Media Relations Department is distributing a release about a study, we will contact the press office of the lead or corresponding author’s institution.

Am I allowed to post a news release on my website?

Embargoed news releases may be posted only to restricted-access websites for journalists. Do not post embargoed news releases to open-access sites. JAMA studies can not be posted on another website, but it is permissible to provide a link to the studies from another website.

How is JAMA promoting my researcher’s paper?

Because of the number of studies published every week in the JAMA Journals, it is not possible to produce a news release for each study. Several studies are selected each week for news releases and distributed to journalists and PIOs. The lead or corresponding author’s institution’s press office will be contacted if a news release is being distributed concerning that study.

Can I distribute my researcher’s JAMA study to reporters?

Although mass distribution of JAMA papers to the media is not allowed, journalists can be directed to the JAMA Media Relations department and/or the For The Media website for the study.

What are the guidelines concerning writing and distributing our own news releases on JAMA studies?

Any news release or media advisory should the have the study’s embargo time, date, and time zone at the top of the release or advisory, and cite in which journal the study appears. Embargoed news releases should only be distributed to journalists. Embargoed information cannot be posted to openly accessible web sites; routed to electronic wire services such as PRNewswire, Ascribe, or BusinessWire; or otherwise placed in the public domain. (These and other open-access services may be used as soon as the embargo lifts, as desired.)